×
For best experience we recommend to activate Javascript in your browser.
MYL3/CMLC1 antibody (N-Term)
This Rabbit Polyclonal antibody specifically detects MYL3/CMLC1 in WB, IHC and ELISA. It exhibits reactivity toward Human.
Quick Overview for MYL3/CMLC1 antibody (N-Term) (ABIN2312167)
Target
See all MYL3/CMLC1 (MYL3) Antibodies
MYL3/CMLC1 (MYL3)
(Myosin, Light Chain 3 (MYL3))
Reactivity
All reactivities for MYL3/CMLC1 antibodies
Human
Host
All hosts for MYL3/CMLC1 antibodies
Rabbit
Clonality
All clonalities for MYL3/CMLC1 antibodies
Polyclonal
Conjugate
All conjugates for MYL3/CMLC1 antibodies
This MYL3/CMLC1 antibody is un-conjugated
Application
All applications for MYL3/CMLC1 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), ELISA
Product Details anti-MYL3/CMLC1 Antibody
(hide)
Binding Specificity
All epitopes for MYL3/CMLC1 antibodies
AA 1-30, N-Term
Cross-Reactivity
Human
Cross-Reactivity (Details)
Calculated cross reactivity: Hu
Characteristics
MYL3, NT (MYL3, Myosin light chain 3, Cardiac myosin light chain 1, Myosin light chain 1, slow-twitch muscle B/ventricular isoform, Ventricular/slow twitch myosin alkali light chain)
Purification
Purified by Protein A affinity chromatography.
Immunogen
MYL3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of human MYL3.
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working conditions should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C
Storage Comment
-20°C
Target Details for MYL3/CMLC1
(hide)
Target
MYL3/CMLC1 (MYL3)
(Myosin, Light Chain 3 (MYL3))
Alternative Name
MYL3
NCBI Accession
NP_000249
UniProt
P08590
Recently viewed
(hide)
Chat with us , powered by LiveChat